Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

KIROPRAKTISK KLINIK RØDOVRE ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6%   Bankruptcy risk   4.7% 1.7% 1.3% 2.0% 1.5% 1.2% 10.0% 9.8%   Credit score (0-100)   47 74 80 68 76 81 25 25   Credit rating   BBB A A A A A BB BB   Credit limit (kDKK)   0.0 2.0 32.6 0.3 12.9 98.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,840 1,842 2,280 1,544 1,673 1,640 0.0 0.0   EBITDA   542 979 713 325 412 779 0.0 0.0   EBIT   454 882 562 155 361 719 0.0 0.0   Pre-tax profit (PTP)   452.5 847.4 559.0 155.3 372.7 752.1 0.0 0.0   Net earnings   442.5 720.7 433.7 119.4 290.7 586.7 0.0 0.0   Pre-tax profit without non-rec. items   452 847 559 155 373 752 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   610 560 409 239 188 128 0.0 0.0   Shareholders equity total   566 1,287 1,721 1,840 2,131 2,717 2,592 2,592   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,138 1,466 2,149 2,143 2,441 3,237 2,592 2,592   Net Debt   -107 -89.5 -174 -178 -171 -232 -2,592 -2,592     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,840 1,842 2,280 1,544 1,673 1,640 0.0 0.0   Gross profit growth   -10.4% 0.1% 23.8% -32.3% 8.3% -2.0% -100.0% 0.0%   Employees   0 0 0 0 0 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,138 1,466 2,149 2,143 2,441 3,237 2,592 2,592   Balance sheet change%   54.7% -31.4% 46.6% -0.3% 13.9% 32.6% -19.9% 0.0%   Added value   541.8 979.3 712.8 324.9 531.4 778.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -138 -147 -302 -340 -102 -120 -128 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   24.7% 47.9% 24.6% 10.0% 21.6% 43.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   25.8% 49.0% 31.1% 7.2% 16.3% 26.6% 0.0% 0.0%   ROI %   54.0% 90.8% 32.0% 7.2% 17.4% 31.0% 0.0% 0.0%   ROE %   128.3% 77.8% 28.8% 6.7% 14.6% 24.2% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   26.5% 87.8% 80.1% 85.9% 87.3% 83.9% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -19.8% -9.1% -24.5% -54.8% -41.4% -29.9% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.2 2.1 0.0 0.0 1.5 1.1 0.0 0.0   Current Ratio   0.2 2.1 0.0 0.0 1.5 1.1 0.0 0.0   Cash and cash equivalent   107.0 89.5 174.3 178.0 170.8 232.5 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -1,296.3 110.8 350.0 334.4 144.7 31.1 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 779 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 779 0 0   EBIT / employee   0 0 0 0 0 719 0 0   Net earnings / employee   0 0 0 0 0 587 0 0